diethyl dihydroxyhomospermine
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2016 (NCT02657330)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sbp-101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05254171 | Phase 2/Phase 3 (Phase 3) | Aug 8, 2022 | Panbela Therapeutics |
| NCT03412799 | Phase 1 | Jun 4, 2018 | Sun BioPharma Inc |
| NCT02657330 | Phase 1 | Jan 1, 2016 | Sun BioPharma Inc |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sun BioPharma Inc | For profit | 2 | 2 | 1 | 2016 |
| Panbela Therapeutics | For profit | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1